Topic starter
06/09/2026 9:34 am
TL;DR: AI agents can accelerate test authoring dramatically, but Arxan Technologies argues that execution capacity, device fragmentation, and orchestration determine whether that automation actually ships. The strategic risk is execution debt: teams can scale test creation faster than they can scale the runtime layer needed to run, trace, and trust the results.
Editorial analysis by NHI Mgmt Group, based on content published by Arxan Technologies: “But Where Are You Going to Run All of Those Tests?”.
Key questions
Q: What breaks when QA automation scales faster than execution capacity?
A: The execution layer becomes the constraint, so tests accumulate faster than they can be run, repeated, or trusted.
Q: Why do shared device labs create governance problems at scale?
A: Because shared labs turn runtime access into a control issue, not just a technical one.
Q: How do teams know if their execution platform is actually keeping up?
A: Look for stable throughput, low queue times, repeatable results across runs, and minimal manual intervention to keep devices healthy.
Practitioner guidance
- Define execution capacity as a governed service Track device pools, browser versions, OS versions, concurrency limits, and queue times as a shared operational metric, not a team-by-team side concern.
- Separate test creation from test execution ownership Assign a clear owner for orchestration, platform health, and runtime reliability so automation authors are not also carrying infrastructure drift.
- Validate coverage against real runtime conditions Require physical-device validation for scenarios that depend on accessibility services, carrier behaviour, audio, or connected-car integrations.
Bottom line: Execution debt appears when automation authoring scales faster than the runtime layer that can actually run the tests.
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
06/09/2026 9:34 am
Execution debt is the right name for the failure mode. The article describes a common scaling trap: teams optimise test creation while underinvesting in the runtime estate that makes those tests useful. That problem is structural, not tactical. Once AI lowers the cost of authoring, the limiting factor shifts to orchestration, capacity, and operational ownership. Practitioners should treat test execution as a governed service, not an informal by-product of automation.
A few things that frame the scale:
- 62% of organisations are at least experimenting with AI agents, but only 23% have scaled one into a single business function, according to McKinsey's 2025 State of AI survey.
A question worth separating out:
Q: Cloud device labs or on-premise execution: which matters more for scale?
A: The deciding factor is not location but whether the platform matches the app’s runtime needs and governance model. Cloud delivery helps when procurement overhead is the bottleneck, while on-premise or hybrid setups matter when teams need control over owned devices, traceability, or specialised hardware scenarios.
👉 Read our full editorial: Execution debt in QA test automation is the real scaling bottleneck